136 related articles for article (PubMed ID: 1544384)
1. Hemopoietic neoplasms in lethally irradiated mice repopulated with bone marrow cells carrying the human c-myc oncogene: a repopulation assay.
Hirabayashi Y; Inoue T; Suda Y; Aizawa S; Ikawa Y; Kanisawa M
Exp Hematol; 1992 Feb; 20(2):167-72. PubMed ID: 1544384
[TBL] [Abstract][Full Text] [Related]
2. A non-transgenic mouse model for B-cell lymphoma: in vivo infection of p53-null bone marrow progenitors by a Myc retrovirus is sufficient for tumorigenesis.
Yu D; Thomas-Tikhonenko A
Oncogene; 2002 Mar; 21(12):1922-7. PubMed ID: 11896625
[TBL] [Abstract][Full Text] [Related]
3. H-2/myc, E mu/myc, and c-myc transgenic mice: potent sources of early hematopoietic cell lines.
Roland J; Morello D
Cell Growth Differ; 1993 Nov; 4(11):891-900. PubMed ID: 8297795
[TBL] [Abstract][Full Text] [Related]
4. The cis-acting elements known to regulate c-myc expression ex vivo are not sufficient for correct transcription in vivo.
Lavenu A; Pournin S; Babinet C; Morello D
Oncogene; 1994 Feb; 9(2):527-36. PubMed ID: 8290263
[TBL] [Abstract][Full Text] [Related]
5. A multicopy c-Myc transgene as a nuclear label: overgrowth of Myctg50 cells in allophenic mice.
Augustin M; Klopp N; Ewald K; Jockusch H
Cell Biol Int; 1998; 22(6):401-11. PubMed ID: 10328848
[TBL] [Abstract][Full Text] [Related]
6. A human immunoglobulin gene reduces the incidence of lymphomas in c-Myc-bearing transgenic mice.
Nussenzweig MC; Schmidt EV; Shaw AC; Sinn E; Campos-Torres J; Mathey-Prevot B; Pattengale PK; Leder P
Nature; 1988 Dec; 336(6198):446-50. PubMed ID: 3143076
[TBL] [Abstract][Full Text] [Related]
7. Evolution of neoplastic development in the liver of transgenic mice co-expressing c-myc and transforming growth factor-alpha.
Santoni-Rugiu E; Nagy P; Jensen MR; Factor VM; Thorgeirsson SS
Am J Pathol; 1996 Aug; 149(2):407-28. PubMed ID: 8701981
[TBL] [Abstract][Full Text] [Related]
8. Experimental manipulations and marrow-derived factors which affect the outcome of bone marrow transplantation across the H-2 barrier in lethally irradiated mice.
Pierpaoli W; Kellerhals R; Buehler A; Sache E
J Clin Lab Immunol; 1985 Mar; 16(3):115-24. PubMed ID: 3897543
[TBL] [Abstract][Full Text] [Related]
9. A new transgenic mouse model for the study of cell cycle control in megakaryocytes.
Thompson A; Zhao Z; Ladd D; Zimmet J; Ravid K
Stem Cells; 1996; 14 Suppl 1():181-7. PubMed ID: 11012219
[TBL] [Abstract][Full Text] [Related]
10. Hemopoietic activity in bone marrow chimeras prepared with total lymphoid irradiation (TLI).
Slavin S; Seidel HJ
Exp Hematol; 1982 Feb; 10(2):206-16. PubMed ID: 7037437
[TBL] [Abstract][Full Text] [Related]
11. Alterations in specific gene expression and focal neoplastic growth during spontaneous hepatocarcinogenesis in albumin-SV40 T antigen transgenic rats.
Dragan YP; Sargent LM; Babcock K; Kinunen N; Pitot HC
Mol Carcinog; 2004 Jul; 40(3):150-9. PubMed ID: 15224347
[TBL] [Abstract][Full Text] [Related]
12. Leukemia inhibitory factor induces in vivo expansion of bone marrow progenitor cells that accelerate hematopoietic reconstitution but do not enhance radioprotection in lethally irradiated mice.
Pruijt JF; Lindley IJ; Heemskerk DP; Willemze R; Fibbe WE
Stem Cells; 1997; 15(1):50-5. PubMed ID: 9007222
[TBL] [Abstract][Full Text] [Related]
13. Generation of macrophage cell line from fresh bone marrow cells with a myc/raf recombinant retrovirus.
Blasi E; Radzioch D; Merletti L; Varesio L
Cancer Biochem Biophys; 1989 Oct; 10(4):303-17. PubMed ID: 2695237
[TBL] [Abstract][Full Text] [Related]
14. Intra-bone marrow injection of donor bone marrow cells suspended in collagen gel retains injected cells in bone marrow, resulting in rapid hemopoietic recovery in mice.
Shi M; Adachi Y; Shigematsu A; Koike-Kiriyama N; Feng W; Yanai S; Yunze C; Lian ZX; Li J; Ikehara S
Stem Cells; 2008 Sep; 26(9):2211-6. PubMed ID: 18599811
[TBL] [Abstract][Full Text] [Related]
15. AID and RAG1 do not contribute to lymphomagenesis in Emu c-myc transgenic mice.
Nepal RM; Zaheen A; Basit W; Li L; Berger SA; Martin A
Oncogene; 2008 Aug; 27(34):4752-6. PubMed ID: 18408759
[TBL] [Abstract][Full Text] [Related]
16. Lymphoproliferative syndrome associated with c-myc expression driven by a class I gene promoter in transgenic mice.
Morello D; Lavenu A; Bandeira A; Portnoi D; Gaillard J; Babinet C
Oncogene Res; 1989; 4(2):111-25. PubMed ID: 2654814
[TBL] [Abstract][Full Text] [Related]
17. Transformation of bone marrow cells from E mu-myc transgenic mice by Abelson murine leukemia virus and Harvey murine sarcoma virus.
Dyall-Smith D; Cory S
Oncogene Res; 1988 May; 2(4):403-9. PubMed ID: 2840624
[TBL] [Abstract][Full Text] [Related]
18. Expression of N-myc, c-myc, and MDR-1 proteins in newly established neuroblastoma cell lines: a study by immunofluorescence staining and flow cytometry.
Gazitt Y; He YJ; Chang L; Koza S; Fisk D; Graham-Pole J
Cancer Res; 1992 May; 52(10):2957-65. PubMed ID: 1374683
[TBL] [Abstract][Full Text] [Related]
19. AlphaIIb integrin expression during development of the murine hemopoietic system.
Corbel C; Salaün J
Dev Biol; 2002 Mar; 243(2):301-11. PubMed ID: 11884039
[TBL] [Abstract][Full Text] [Related]
20. Antileukemic effect of interleukin-2-transduced murine bone marrow after autologous transplantation.
Tam YK; Klingemann HG
Biol Blood Marrow Transplant; 1999; 5(4):231-42. PubMed ID: 10465103
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
